eMagin (NYSE:EMA – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a research report issued on Saturday, Wall Street Zen reports.
Several other equities analysts have also issued reports on EMA. Barclays lowered their price target on eMagin from $53.00 to $50.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Weiss Ratings upgraded shares of eMagin from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, October 23rd. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, eMagin currently has an average rating of “Hold” and a consensus target price of $50.00.
Read Our Latest Analysis on EMA
eMagin Stock Down 0.1%
NYSE EMA opened at $49.25 on Friday. The stock has a 50-day moving average of $48.56 and a two-hundred day moving average of $51.12. eMagin has a 1-year low of $45.27 and a 1-year high of $55.49.
Institutional Investors Weigh In On eMagin
Hedge funds have recently modified their holdings of the stock. Rathbones Group PLC grew its stake in shares of eMagin by 0.3% during the 1st quarter. Rathbones Group PLC now owns 58,900 shares of the company’s stock valued at $3,043,000 after purchasing an additional 200 shares during the period. Parallel Advisors LLC grew its stake in eMagin by 130.9% in the 1st quarter. Parallel Advisors LLC now owns 508 shares of the company’s stock valued at $26,000 after acquiring an additional 288 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of eMagin by 54.4% in the first quarter. EverSource Wealth Advisors LLC now owns 1,093 shares of the company’s stock worth $57,000 after buying an additional 385 shares during the period. Gold Investment Management Ltd. bought a new position in eMagin in the 3rd quarter valued at about $27,000. Finally, Mather Group LLC. bought a new position in shares of eMagin during the 3rd quarter valued at $38,000.
eMagin Company Profile
eMagin Corporation was a U.S.-based developer and manufacturer of high-resolution organic light-emitting diode (OLED) microdisplays. Its products were designed for applications requiring compact, lightweight displays with high image quality, including defense, aerospace, medical, industrial, and consumer systems.
The company’s product portfolio included active-matrix OLED microdisplays, display modules, and related display solutions. These technologies were used in applications such as night-vision and thermal-imaging equipment, helmet-mounted and head-up displays, avionics, training systems, and emerging augmented- and virtual-reality devices.
Founded in 1996 and headquartered in Hopewell Junction, New York, eMagin served customers in the United States and international markets, with a significant focus on government and defense programs.
Featured Articles
- Five stocks we like better than eMagin
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for eMagin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin and related companies with MarketBeat.com's FREE daily email newsletter.
